Transplantation and ECMO feature prominently in Saturday session

 

Saturday’s course “Cardiothoracic Transplant and Mechanical Circulatory Support of Heart and Lung Failure: Mastery of the Management of End Stage Heart and Lung Disease” will explore novel techniques in heart and lung transplant, mechanical circulatory support, and extracorporeal membrane oxygenation (ECMO). The course is co-chaired by Matthew D. Bacchetta, MD, of Columbia University, Carmelo A. Milano, of Duke University, and Rich Walczak, CCP, FPP, also of Duke University.

The first session will focus on heart transplants, and will cover topics such as perfusion storage for transplantation, maintaining an ex-vivo heart, primary graft dysfunction and a talk from Yoshifumi Naka, MD, of Columbia University, who will provide first-hand accounts of using the latest durable centrifugal left ventricular assist device (LVAD).

Following the talks on heart transplants will be a session on lung transplantation. This session will include discussions on primary graft dysfunction, techniques for performing transplantations in patients with pulmonary hypertension, and a talk on bioengineered lungs, the latter of which will be given by Harald C. Ott, MD, of Massachusetts General Hospital.

“We’re going to get a very comprehensive update on the use of donation after cardiac death (DCD) lung transplantation, which is obviously a hot topic in our field right now,” explained Dr. Bacchetta. DCD will also be discussed in relation to heart transplants.

After lunch, mechanical circulatory support will take center stage. Presentations will range from dealing with LVAD and BiVAD support, to avoiding and treating pump thrombosis, and techniques for troubleshooting implantable devices. The course will close with a session on ECMO with Dr. Bacchetta presenting on ECMO bridge to transplantation (BTT), while other talks consider artificial lung development, ECMO transport, management of ambulation during ECMO, and ex vivo lung perfusion.

Dr. Bacchetta said, “We’ll be getting really good reviews from some of the best centers around the world.”

 

Saturday’s course “Cardiothoracic Transplant and Mechanical Circulatory Support of Heart and Lung Failure: Mastery of the Management of End Stage Heart and Lung Disease” will explore novel techniques in heart and lung transplant, mechanical circulatory support, and extracorporeal membrane oxygenation (ECMO). The course is co-chaired by Matthew D. Bacchetta, MD, of Columbia University, Carmelo A. Milano, of Duke University, and Rich Walczak, CCP, FPP, also of Duke University.

The first session will focus on heart transplants, and will cover topics such as perfusion storage for transplantation, maintaining an ex-vivo heart, primary graft dysfunction and a talk from Yoshifumi Naka, MD, of Columbia University, who will provide first-hand accounts of using the latest durable centrifugal left ventricular assist device (LVAD).

Following the talks on heart transplants will be a session on lung transplantation. This session will include discussions on primary graft dysfunction, techniques for performing transplantations in patients with pulmonary hypertension, and a talk on bioengineered lungs, the latter of which will be given by Harald C. Ott, MD, of Massachusetts General Hospital.

“We’re going to get a very comprehensive update on the use of donation after cardiac death (DCD) lung transplantation, which is obviously a hot topic in our field right now,” explained Dr. Bacchetta. DCD will also be discussed in relation to heart transplants.

After lunch, mechanical circulatory support will take center stage. Presentations will range from dealing with LVAD and BiVAD support, to avoiding and treating pump thrombosis, and techniques for troubleshooting implantable devices. The course will close with a session on ECMO with Dr. Bacchetta presenting on ECMO bridge to transplantation (BTT), while other talks consider artificial lung development, ECMO transport, management of ambulation during ECMO, and ex vivo lung perfusion.

Dr. Bacchetta said, “We’ll be getting really good reviews from some of the best centers around the world.”

 

Saturday’s course “Cardiothoracic Transplant and Mechanical Circulatory Support of Heart and Lung Failure: Mastery of the Management of End Stage Heart and Lung Disease” will explore novel techniques in heart and lung transplant, mechanical circulatory support, and extracorporeal membrane oxygenation (ECMO). The course is co-chaired by Matthew D. Bacchetta, MD, of Columbia University, Carmelo A. Milano, of Duke University, and Rich Walczak, CCP, FPP, also of Duke University.

The first session will focus on heart transplants, and will cover topics such as perfusion storage for transplantation, maintaining an ex-vivo heart, primary graft dysfunction and a talk from Yoshifumi Naka, MD, of Columbia University, who will provide first-hand accounts of using the latest durable centrifugal left ventricular assist device (LVAD).

Following the talks on heart transplants will be a session on lung transplantation. This session will include discussions on primary graft dysfunction, techniques for performing transplantations in patients with pulmonary hypertension, and a talk on bioengineered lungs, the latter of which will be given by Harald C. Ott, MD, of Massachusetts General Hospital.

“We’re going to get a very comprehensive update on the use of donation after cardiac death (DCD) lung transplantation, which is obviously a hot topic in our field right now,” explained Dr. Bacchetta. DCD will also be discussed in relation to heart transplants.

After lunch, mechanical circulatory support will take center stage. Presentations will range from dealing with LVAD and BiVAD support, to avoiding and treating pump thrombosis, and techniques for troubleshooting implantable devices. The course will close with a session on ECMO with Dr. Bacchetta presenting on ECMO bridge to transplantation (BTT), while other talks consider artificial lung development, ECMO transport, management of ambulation during ECMO, and ex vivo lung perfusion.

Dr. Bacchetta said, “We’ll be getting really good reviews from some of the best centers around the world.”